Infection as a cause of age-related morbidity and mortality

Ageing Research Reviews

Volumn 3, Issue 1, 2004, Pages 1-14

  High, Kevin P ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; DOXYCYCLINE; MACROLIDE; METICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; VANCOMYCIN;

AGED; AGING; ANTIMICROBIAL ACTIVITY; APPENDICITIS; BACTERIAL INFECTION; BEHAVIOR; CANCER; CEREBROVASCULAR DISEASE; COMORBIDITY; CULTURAL ANTHROPOLOGY; DEVELOPING COUNTRY; DIABETES MELLITUS; DISEASE PREDISPOSITION; DRUG RESISTANCE; ECONOMIC ASPECT; ENDOCARDITIS; HEALTH CARE; HEART DISEASE; HOST RESISTANCE; HUMAN; INFECTION RISK; INFLUENZA; LIFE EXPECTANCY; LONG TERM CARE; LUNG DISEASE; MORBIDITY; MORTALITY; PNEUMONIA; POPULATION RESEARCH; REVIEW; SEPSIS; SOCIAL ENVIRONMENT; TUBERCULOSIS;

BACTERIA (MICROORGANISMS);

EID: 0842324563     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arr.2003.08.001     Document Type: Review

References (62)

1. Adler W.H., Basker P.V., Chrest F.J.et al. HIV infection and aging: mechanisms to explain the accelerated rate of progression in the older patient. Mech. Ageing Dev. 96:1997;137-155.
2. Bentley D.W., Bradley S., High K.et al. Practice guideline for evaluation of fever and infection in long-term care facilities. Clin. Infect. Dis. 31:2000;640-653.
3. Berner Y.N., Lang R., Chowers M.Y. Outcome of West Nile Fever in Older Adults. J. Am. Geriatr. Soc. 50:2002;1844-1846.
4. Bestiliny L.J., Gill M.F., Mody C.H., RIabolwo K.T. Accelerated replicative senescence of the peripheral immune system induced by HIV infection. AIDS. 14:2000;771-780.
5. Bradley S.F. Issues in the management of resistant bacteria in long-term-care facilities. Infect. Control Hosp. Epidemiol. 20:1999;362-366.
6. Bradley S.F. Methicillin-resistant Staphylococcus aureus: long-term care concerns. Am. J. Med. 106(5A):1999;2S-10S.
7. Brassard P., Bourgault C., Brophy J.et al. Antibiotics in primary prevention of myocardial infarction among elderly patients with hypertension. Am. Heart. J. 145:2003;918. (electronic article E25).
8. Bruunsgaard H., Skinhog P., Qvist J., Pedersen B.K. Elderly humans show prolonged in vivo inflammatory activity during pneumnococcal infections. J. Infect. Dis. 180:1999;551-554.
9. Castle S.C., Yeh M., Toledo T.T., Norman D.C. Lowering the fever criteria improves detection of infections in nursing home residents. Aging Immunol. Infect. Dis. 4:1993;67-76.
10. Cawthorn R.M., Smith K.R., O'Brien E.et al. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 361:2003;393-395.
11. Cercek B., Shah P.K., Noc M.et al. Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomized controlled trial. Lancet. 361:2003;809-813.
12. Connoy, A., Li, L., High, K.P., 2003. Increased NFkB Activation and IRAK-1 Expression in Spleen but Not Liver of Old Adult Mice. American Federation of Aging Researchers, Los Angeles, CA.
13. Crossley K. Vancomycin-resistant enterococci in long-term-care facilities. Infect Control Hosp. Epidemiol. 19:1998;521-525.
14. Danesh J., Collens R., Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 350:1997;430-436.
15. Espinola-Klein C., Rupprecht H.J., Blankenberg S.et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation. 105:2002;15-21.
16. Evans R.G., Stoddart G.L. Producing health, consuming health care. Soc. Sci. Med. 31:1990;1347-1363.
17. Fein A.M. Pneumonia in the elderly: overview of diagnostic and therapeutic approaches. Clin. Infect. Dis. 28:1999;726-729.
18. Franceschi C., Bonafe M., Valensin S.et al. Inflamm-aging: An Evolutionary Perspective on Immunosenescence. Ann. N.Y. Acad. Sci. 908:2000;244-254.
19. Franck, J.N., Schwab, E.O., Bentley, D.W., 2002. In: Yoshikawa, T.T., Ouslander, J.G. (Eds.), Establishing an Infection Control Program in Infection Management for Geriatrics in Long-Term Care Facilities. Marcel Dekker, Inc., New York, pp. 115-131.
20. Gavazzi G., Krause K.-H. Ageing and infection. Lancet, Infect. Dis. 2:2002;659-666.
21. Gavazzi G., Mallaret M.-R., Couturier P.et al. Bloodstream infection: differences between young-old, old, and old-old patients. J. Amer. Geriatr. Soc. 50:2002;1667-1673.
22. Glezen W.P., Greenberg S.B., Atmar R.L., Piedra P.A., Couch R.B. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 283:2000;499-505.
23. High K.P. Atherosclerosis and infection due to Chlamydia pneumoniae or cytomegalovirus: weighing the evidence. Clin. Infect. Dis. 28:1999;746-749.
24. Hoyert, D.L., Arias, E., et al., 2001. Deaths: Final Data for 1999. National Vital Statistics Reports, vol. 49, no 8. Hyattsville, MD, National Center for Health Statistics.
25. Incalzi R.A., Maini C.L., Fuso L.et al. Effects of aging on mucociliary clearance. Compr. Gerontol. [A]. 3:1989;65-68.
26. Kauffman C.A., Hedderwick S.A., Bradley S.F. Antibiotic resistance: issues in long-term care. Infect. Med. 16:1999;122-128.
27. Kemper P., Murtaugh D.M. Lifetime use of nursing home care. N. Engl. J. Med. 324:1991;595-600.
28. Kinsella, K., Velkoff, V.A., 2001. US Census Bureau, Series P95/01-1, An Aging World: 2001, US Government Printing Office, Washington, DC.
29. Klontz K.C., Adler W.H., Potter M. Age-dependent resistance factors in the pathogenesis of foodborne infectious disease. Aging. 9:1997;320-326.
30. Kuipers E.J., Uyterlinde A.M., Pena A.S.et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet. 345:1995;1525-1528.
31. Loeb M.B. Community-acquired pneumonia in older people: the need for a broader perspective. J. Am. Geriatr. Soc. 51:2003;539-543.
32. Loeb M., McGeer A., MacArthur M., Walter S., Simor A. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch. Intern. Med. 159:1999;2058-2064.
33. Loeb M., Simor A.E., Landry L.et al. Antibiotic use in Ontario facilities that provide chronic care. J. Gen. Intern. Med. 16:2001;376-383.
34. Loeb, M., Molloy, W., Smieja, M., et al., 2003. A Randomized Controlled Trial of Doxycycline and Rifampin for Patients with Alzheimer Disease. Infectious Diseases Society of America, San Diego, CA, AB 751.
35. Luchsinger J.A., Pablos-Mendez A., Knirsch C.et al. Am. J. Cardiol. 89:2002;18-21.
36. Meier C.R., Derby L.E., Jick S.S.et al. Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA. 281:1999;427-431.
37. Meyer K.C. The role of immunity in susceptibility to respiratory infection in the aging lung. Respir. Physiol. 128:2001;23-31.
38. Minino A.M., Smith B.L., Deaths: Preliminary data for 2000. National Vital Statistics Reports, vol. 49, no. 12. National Center for Health Statistics, Hyattsville, MD.
39. Mooser V. Atherosclerosis and HIV in the highly active antiretroviral therapy era: towards an epidemic of cardiovascular disease? AIDS. 17(Suppl. 1):2003;S65-S69.
40. Muto C.A., Jernigan J.A., Ostrowsky B.E.et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect. Control Hosp. Epidemiol. 24:2003;362-386.
41. Nash D., Mostashari F., Fine A.et al. The outbreak of West Nile virus infection in the New York City area in 1999. N. Engl. J. Med. 344:2001;1807-1814.
42. Nicolle L.E., Bentley D., Garibaldi R.et al. Antimicrobial use in long-term-care facilities. Infect. Control Hosp. Epidemiol. 17:1996;119-128.
43. Norman, D.C., 2001. Clinical features of infections. In: Yoshikawa, T.T., Norman, D.C. (Eds.), Infectious Disease in the Aging. Humana Press, Totowa, NJ, 2001, pp. 13-18.
44. Perez J.L., Moore R.D. Greater effect of highly active antiretroviral therapy on survival in people aged > or =50 years compared with younger people in an urban observational cohort. Clin. Infect. Dis. 36:2003;212-218.
45. Pilotto A., Malfertheiner P. An approach to Helicobacter pylori infection in the elderly. Aliment Pharmacol. Ther. 16:2002;683-691.
46. Richards, C.L., Jr., Jarvis W.R., 2002. Epidemiologic investigation of infectious disease outbreaks. In: Yoshikawa, T.T., Ouslander, J.G. (Eds.), Infection Management for Geriatrics in Long-Term Care Facilities. Marcel Dekker, Inc., New York, pp. 133-153.
47. Ridker P.M., Rifai N., Rose L.et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 347:2002;1557-1565.
48. Roghmann M.C., Warner J., MacKowiak P.A. The relationship between age and fever magnitude. Am J. Med. Sci. 322:2001;68-70.
49. Rupprecht H.J., Blankenberg S., Bickel C.et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation. 104:2001;25-31.
50. Sonderson S.R., Essen M.V., Schjerling P.et al. Proliferation and telomere length in acutely mobilized blood mononuclear cells in HIV infected patients. Clin. Exp. Immunol. 127:2002;499-506.
51. Spencer M.F., Poynter M.E., Im S.Y., Daynes R.A. Constitutive activation of NF-kappa B in an animal model of aging. Int. Immunol. 9:1997;1581-1588.
52. Strausbaugh L., Crossley K.B., Nurse B.A., Thrupp L.D. Antimicrobial resistance in long-term-care facilities. Infect. Control Hosp. Epidemiol. 17:1996;129-140.
53. Strausbaugh L.J., Joseph C.L. The burden on infection in long-term care. Infect. Control Hosp. Epidemiol. 21:2000;674-679.
54. Strausbaugh L.J., Sukumar S.R., Joseph C.L. Infectious disease outbreaks in nursing homes: an unappreciated hazard for frail elderly persons. Clin. Infect. Dis. 36:2003;870-876.
55. Thomas J., Doherty S.M. HIV infection - a risk factor for osteoporosis. J. Acquir. Immune Defic. Syndr. 33:2003;281-291.
56. Thompson W.W., Shay D.K., Weintraub E.et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 289:2003;179-186.
57. Toubes E., Singh K., Yin D.et al. Risk factors for antibiotic-resistant infection and treatment outcomes among hospitalized patients transferred from long-term care facilities: does antimicrobial choice make a difference? Clin. Infect. Dis. 36:2003;724-730.
58. Trick W.E., Weinstein R.A., DeMarais P.L.et al. Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J. Am. Geriatr. Soc. 49:2001;270-276.
59. Tucker V., Jenkins J., Gilmour J.et al. T-cell telomere length maintained in HIV-infected long-term survivors. HIV Med. 1:2000;116-122.
60. Vittecoq D., Escaut L., Chironi G.et al. Coronary heart disease in HIV-infected patients in the highly active antiretroviral treatment era. AIDS. 17(Suppl. 1):2003;S70-S76.
61. Yoshikawa T.T. Perspective: aging and infectious diseases: past, present, and future. J. Infect. Dis. 176:1997;1053-1057.
62. Zahn R., Schneider S., Frilling B.et al. Antibiotic therapy after acute myocardial infarction: a prospective randomized study. Circulation. 107:2003;1253-1259.